• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dialogue, Collaboration, and Innovations in Oncology

Video

In the first segment of this one-on-one interview series, Peter Salgo, MD, and Bryan Loy, MD, of Humana discuss the most influential recent innovations in cancer care.

Dr Loy comments that in addition to the targeted tests and therapies that continue to emerge, he finds remarkable the willingness of key stakeholders to collaborate and discuss the utilization of newer technologies, their costs, and the overall patient experience.

Dr Loy explains that understanding the role that genetics plays in cancer is important, and being able to comprehend the data and engage in dialogues regarding how to utilize emerging therapies can help all stakeholders in medical oncology deliver better quality care.

Because health literacy continues to be a real issue for patients, patients must be presented with information on these emerging treatment options in an understandable form. Additionally, everyone involved in patient care, from caregivers to those involved in reimbursement, should be accountable for sharing information with patients, suggests Dr Loy.

Watch our related Peer Exchange, Oncology Stakeholder Summit 2014: Evidence-Based Decisions to Improve Quality and Regulate Costs


Related Videos
Glenn Balasky, executive director of the Rocky Mountain Cancer Center.
Screenshot of an interview with James Chambers, PhD
Corey McEwen, PharmD, MS
dr linda bosserman
dr andrew leitner
Glenn Balasky during a video interview
dr joseph alvarnas
dr joseph alvarnas
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.